US Stock MarketDetailed Quotes

Monte Rosa Therapeutics (GLUE)

Watchlist
  • 18.700
  • +0.470+2.58%
Close Apr 16 16:00 ET
  • 18.700
  • 0.0000.00%
Post 17:17 ET
1.50BMarket Cap-40.65P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Monte Rosa Therapeutics (GLUE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-154.29%-22.8M
-133.36%-43.01M
578.37%100.43M
-25.04%-34.72M
-19.20%-45.49M
195.88%42M
335.05%128.92M
15.02%-20.99M
-9.65%-27.77M
-63.06%-38.17M
Net income from continuing operations
46.87%-38.63M
-443.34%-46.14M
-13.50%-27.08M
59.44%-12.3M
246.66%46.89M
46.29%-72.7M
140.41%13.44M
31.60%-23.86M
13.84%-30.31M
0.22%-31.97M
Operating gains losses
---59K
--0
--0
--0
---59K
----
----
----
----
----
Depreciation and amortization
2.89%8.36M
1.31%2.09M
-0.38%2.1M
3.16%2.13M
7.96%2.05M
30.52%8.12M
11.65%2.06M
14.67%2.1M
48.09%2.06M
64.81%1.9M
Change In working capital
-110.05%-9.19M
-103.07%-3.36M
5,098.60%121.52M
-881.44%-28.71M
-664.73%-98.64M
26.12%91.4M
90.03%109.65M
-155.59%-2.43M
-150.89%-2.93M
-377.85%-12.9M
-Change in receivables
-3,541.87%-11.43M
-1,672.27%-6.64M
-128.07%-2.6M
89.70%-961K
-12,250.00%-1.24M
-82.50%332K
225.60%422K
2,365.87%9.25M
-4,683.08%-9.33M
-100.49%-10K
-Change in prepaid assets
138.04%604K
-58.95%1.38M
137.22%941K
-1,267.20%-1.71M
99.83%-4K
-247.45%-1.59M
338.17%3.35M
-975.74%-2.53M
-106.70%-125K
-73.26%-2.29M
-Change in payables and accrued expense
-156.11%-5.86M
-111.04%-1.88M
25,735.29%13.07M
-246.55%-3.57M
-50.51%-13.48M
12.03%10.44M
140.97%17.01M
-101.47%-51K
38.29%2.44M
-200.64%-8.96M
-Change in other working capital
-90.89%7.49M
-95.75%3.77M
1,309.99%110.1M
-649.38%-22.46M
-5,001.28%-83.92M
36.63%82.22M
76.98%88.87M
-1,298.81%-9.1M
76.78%4.09M
-123.88%-1.65M
Cash from discontinued investing activities
Operating cash flow
-154.29%-22.8M
-133.36%-43.01M
578.37%100.43M
-25.04%-34.72M
-19.20%-45.49M
195.88%42M
335.05%128.92M
15.02%-20.99M
-9.65%-27.77M
-63.06%-38.17M
Investing cash flow
Cash flow from continuing investing activities
-129.09%-101.83M
-110.60%-65.07M
1.03%38.14M
141.41%25.32M
-1,117.24%-100.23M
-150.06%-44.45M
-316.10%-30.9M
5.95%37.75M
-429.69%-61.16M
-51.53%9.85M
Net PPE purchase and sale
-17.85%-4.7M
-319.13%-767K
-63.16%-651K
16.17%-1.7M
-14.67%-1.59M
78.99%-3.99M
89.17%-183K
75.95%-399K
68.65%-2.02M
84.93%-1.38M
Net investment purchase and sale
-140.05%-97.13M
-109.35%-64.3M
1.68%38.79M
145.69%27.02M
-977.83%-98.64M
-137.54%-40.46M
-292.12%-30.71M
2.31%38.15M
-336.54%-59.14M
-61.92%11.24M
Cash from discontinued investing activities
Investing cash flow
-129.09%-101.83M
-110.60%-65.07M
1.03%38.14M
141.41%25.32M
-1,117.24%-100.23M
-150.06%-44.45M
-316.10%-30.9M
5.95%37.75M
-429.69%-61.16M
-51.53%9.85M
Financing cash flow
Cash flow from continuing financing activities
-69.31%30.35M
4,772.37%29.62M
2,220.00%348K
-99.63%365K
-94.31%14K
259.71%98.89M
-97.58%608K
-98.64%15K
8,068.58%98.02M
1,266.67%246K
Net common stock issuance
7,785.48%23.89M
150.84%23.89M
--0
----
----
361.21%303K
-40,418.10%-47M
---641K
----
----
Proceeds from stock option exercised by employees
-87.48%6.46M
842.60%5.73M
2,220.00%348K
-99.28%365K
-94.31%14K
86.86%51.59M
-97.60%608K
-98.64%15K
4,126.58%50.72M
1,266.67%246K
Net other financing activities
----
----
----
----
----
--47M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-69.31%30.35M
4,772.37%29.62M
2,220.00%348K
-99.63%365K
-94.31%14K
259.71%98.89M
-97.58%608K
-98.64%15K
8,068.58%98.02M
1,266.67%246K
Net cash flow
Beginning cash position
72.68%229.12M
63.46%213.29M
-34.59%74.38M
-20.27%83.41M
72.68%229.12M
120.44%132.68M
105.24%130.48M
120.57%113.71M
83.12%104.62M
120.44%132.68M
Current changes in cash
-197.76%-94.28M
-179.54%-78.46M
728.35%138.91M
-199.26%-9.03M
-419.16%-145.71M
33.03%96.44M
42.73%98.63M
39.48%16.77M
263.22%9.1M
-816.59%-28.07M
End cash Position
-41.15%134.84M
-41.15%134.84M
63.46%213.29M
-34.59%74.38M
-20.27%83.41M
72.68%229.12M
72.68%229.12M
105.24%130.48M
120.57%113.71M
83.12%104.62M
Free cash flow
-172.35%-27.5M
-134.01%-43.78M
566.40%99.78M
-22.24%-36.42M
-19.04%-47.08M
160.48%38.01M
360.69%128.74M
18.86%-21.39M
6.43%-29.79M
-21.36%-39.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -154.29%-22.8M-133.36%-43.01M578.37%100.43M-25.04%-34.72M-19.20%-45.49M195.88%42M335.05%128.92M15.02%-20.99M-9.65%-27.77M-63.06%-38.17M
Net income from continuing operations 46.87%-38.63M-443.34%-46.14M-13.50%-27.08M59.44%-12.3M246.66%46.89M46.29%-72.7M140.41%13.44M31.60%-23.86M13.84%-30.31M0.22%-31.97M
Operating gains losses ---59K--0--0--0---59K--------------------
Depreciation and amortization 2.89%8.36M1.31%2.09M-0.38%2.1M3.16%2.13M7.96%2.05M30.52%8.12M11.65%2.06M14.67%2.1M48.09%2.06M64.81%1.9M
Change In working capital -110.05%-9.19M-103.07%-3.36M5,098.60%121.52M-881.44%-28.71M-664.73%-98.64M26.12%91.4M90.03%109.65M-155.59%-2.43M-150.89%-2.93M-377.85%-12.9M
-Change in receivables -3,541.87%-11.43M-1,672.27%-6.64M-128.07%-2.6M89.70%-961K-12,250.00%-1.24M-82.50%332K225.60%422K2,365.87%9.25M-4,683.08%-9.33M-100.49%-10K
-Change in prepaid assets 138.04%604K-58.95%1.38M137.22%941K-1,267.20%-1.71M99.83%-4K-247.45%-1.59M338.17%3.35M-975.74%-2.53M-106.70%-125K-73.26%-2.29M
-Change in payables and accrued expense -156.11%-5.86M-111.04%-1.88M25,735.29%13.07M-246.55%-3.57M-50.51%-13.48M12.03%10.44M140.97%17.01M-101.47%-51K38.29%2.44M-200.64%-8.96M
-Change in other working capital -90.89%7.49M-95.75%3.77M1,309.99%110.1M-649.38%-22.46M-5,001.28%-83.92M36.63%82.22M76.98%88.87M-1,298.81%-9.1M76.78%4.09M-123.88%-1.65M
Cash from discontinued investing activities
Operating cash flow -154.29%-22.8M-133.36%-43.01M578.37%100.43M-25.04%-34.72M-19.20%-45.49M195.88%42M335.05%128.92M15.02%-20.99M-9.65%-27.77M-63.06%-38.17M
Investing cash flow
Cash flow from continuing investing activities -129.09%-101.83M-110.60%-65.07M1.03%38.14M141.41%25.32M-1,117.24%-100.23M-150.06%-44.45M-316.10%-30.9M5.95%37.75M-429.69%-61.16M-51.53%9.85M
Net PPE purchase and sale -17.85%-4.7M-319.13%-767K-63.16%-651K16.17%-1.7M-14.67%-1.59M78.99%-3.99M89.17%-183K75.95%-399K68.65%-2.02M84.93%-1.38M
Net investment purchase and sale -140.05%-97.13M-109.35%-64.3M1.68%38.79M145.69%27.02M-977.83%-98.64M-137.54%-40.46M-292.12%-30.71M2.31%38.15M-336.54%-59.14M-61.92%11.24M
Cash from discontinued investing activities
Investing cash flow -129.09%-101.83M-110.60%-65.07M1.03%38.14M141.41%25.32M-1,117.24%-100.23M-150.06%-44.45M-316.10%-30.9M5.95%37.75M-429.69%-61.16M-51.53%9.85M
Financing cash flow
Cash flow from continuing financing activities -69.31%30.35M4,772.37%29.62M2,220.00%348K-99.63%365K-94.31%14K259.71%98.89M-97.58%608K-98.64%15K8,068.58%98.02M1,266.67%246K
Net common stock issuance 7,785.48%23.89M150.84%23.89M--0--------361.21%303K-40,418.10%-47M---641K--------
Proceeds from stock option exercised by employees -87.48%6.46M842.60%5.73M2,220.00%348K-99.28%365K-94.31%14K86.86%51.59M-97.60%608K-98.64%15K4,126.58%50.72M1,266.67%246K
Net other financing activities ----------------------47M----------------
Cash from discontinued financing activities
Financing cash flow -69.31%30.35M4,772.37%29.62M2,220.00%348K-99.63%365K-94.31%14K259.71%98.89M-97.58%608K-98.64%15K8,068.58%98.02M1,266.67%246K
Net cash flow
Beginning cash position 72.68%229.12M63.46%213.29M-34.59%74.38M-20.27%83.41M72.68%229.12M120.44%132.68M105.24%130.48M120.57%113.71M83.12%104.62M120.44%132.68M
Current changes in cash -197.76%-94.28M-179.54%-78.46M728.35%138.91M-199.26%-9.03M-419.16%-145.71M33.03%96.44M42.73%98.63M39.48%16.77M263.22%9.1M-816.59%-28.07M
End cash Position -41.15%134.84M-41.15%134.84M63.46%213.29M-34.59%74.38M-20.27%83.41M72.68%229.12M72.68%229.12M105.24%130.48M120.57%113.71M83.12%104.62M
Free cash flow -172.35%-27.5M-134.01%-43.78M566.40%99.78M-22.24%-36.42M-19.04%-47.08M160.48%38.01M360.69%128.74M18.86%-21.39M6.43%-29.79M-21.36%-39.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -